ライフサイエンスコーパス: radioprotective

1 does not explain the differences between the radioprotective activities of nitroxides and hydroxylami

2 Quercetin-3-O-rhamnoside showed the highest radioprotective activity (50% according to control).

3 pondin-1/CD47 antagonists may have selective radioprotective activity for normal tissues.

4 CBLB502 also showed radioprotective activity in lethally irradiated rhesus m

5 hput screening method for the examination of radioprotective activity of chemical compounds using rat

6 Instead, the radioprotective activity of nitroxides, but not of hydro

7 ise to c-Kit(pos) cells with CFU-s activity, radioprotective activity, and PHSC activity.

8 xylamines, are better reductants yet have no radioprotective activity.

9 define molecular mechanisms underlying this radioprotective activity.

10 rial lipopolysaccharide, which is normally a radioprotective agent, is radiosensitizing in IKKbeta-de

11 thiazolidine prodrug forms of the well-known radioprotective agents L-cysteine, cysteamine, and 2-[(a

12 r therapy and that RLIP76 liposomes could be radioprotective agents useful for treatment of iatrogeni

13 The best correlation between radioprotective and antiradical activities of the invest

14 ymphocytes in SCID mice, and stem cells with radioprotective and competitive long-term repopulating a

15 -oncogenes such as K-/H-/N-RAS may provide a radioprotective and growth-promoting signal.

16 ctional hematopoietic progenitor cells, were radioprotective, and performed as well as KLF4(+/+) cell

17 and vegetables have been reported to exhibit radioprotective, antithrombotic, nephro and hepato-prote

18 of 4 Gy (by a factor of 2.84 [P < 0.01]) but radioprotective at radiation doses of 1, 8, and 12 Gy (b

19 nstitution kinetics when cotransplanted with radioprotective bone marrow cells.

20 A prototype and then a final manufactured radioprotective brassiere was constructed and tested for

21 Allogeneic full-term fetal blood has poorer radioprotective capacity but greater long-term engraftme

22 sting that day 8 CFU-S are the precursors of radioprotective cell subsets.

23 is nearly 40 times greater than that of the radioprotective dendritic fullerene, DF-1.

24 nsible for engraftment in syngeneic hosts at radioprotective doses, and higher doses of HSCs can radi

25 This diurnal radioprotective effect becomes lost in circadian mutants

26 f SMPDL3b and pretreatment with RTX confer a radioprotective effect in cultured podocytes.

27 olon cancer cells, a concentration dependent radioprotective effect in mouse thymocytes was demonstra

28 The mechanism of this radioprotective effect involves the binding of apobec-1

29 Thbd or aPC could reproduce and augment the radioprotective effect of the endogenous Thbd-aPC pathwa

30 Thus, the radioprotective effect of TNFalpha was mediated by TAM-p

31 rst study to assay these compounds for their radioprotective effect on human cell lymphocytes in resp

32 ATM/ATR and Chk1/Chk2 kinases abolished the radioprotective effects in TLR9-stimulated cells.

33 On the basis of the radioprotective effects of flagellin, we hypothesized th

34 The radioprotective effects of lipopolysaccharide could be e

35 A accumulation in vitro, suggesting that the radioprotective effects of rIL-11 may be mediated, at le

36 The antioxidant and radioprotective effects of the phenolic glycosides from

37 These results indicate that Bmi-1 elicits radioprotective effects on NHK by mitigating the genotox

38 nd, if so, to determine the mechanism of its radioprotective effects.

39 t mRNA translation that involves mTOR and is radioprotective, enhancing the translation of a subset o

40 ate RNF8 binding as a key determinant of the radioprotective function of ATDC.

41 ation at Ser-550 by MK2 was required for the radioprotective function of ATDC.

42 t nick sealing activity is important for the radioprotective function of DraRnl.

43 ccurring EGFR mutations that lack a critical radioprotective function of EGFR, providing valuable ins

44 of hematopoietic stem cells (HSCs), impaired radioprotective function of hematopoietic progenitor cel

45 Lipopolysaccharide is known to be radioprotective in the bone marrow, but its effect on th

46 sought to determine if lipopolysaccharide is radioprotective in the intestine and, if so, to determin

47 Lipopolysaccharide is radioprotective in the mouse intestine through a prostag

48 Lipopolysaccharide was radioprotective in wild-type mice but not in mice with a

49 The use of in-plane overlying bismuth radioprotective latex manufactured into form-fitting gar

50 e performed with four thicknesses of bismuth radioprotective latex over the breast.

51 The use of bismuth radioprotective latex saved an average 57% of the radiat

52 with the same thickness of overlying bismuth radioprotective latex, with similar results.

53 y irradiated Ly-5.1 mice together with 10(5) radioprotective Ly-5.1 BM cells whose long-term repopula

54 towards radiation risks and adopt adjunctive radioprotective measures.

55 e marrow progenitors but also for cells with radioprotective or marrow repopulating function in vivo.

56 d for screening for compounds with promising radioprotective potential.

57 wed weaker antiradical activities, but their radioprotective potentials were higher than those of the

58 a tumor-specific radiosensitizing agent with radioprotective properties in normal cells.

59 IL-1 has putative chemo- and radioprotective properties, but its effects on primitive

60 Significant radioprotective/radiomitigative effects of imidazole-sub

61 we demonstrate that RelB plays an important radioprotective role in aggressive prostate cancer cells

62 Radioprotective strategies can be classified under the c

63 Pharmacologic radioprotective strategies should be integrated with phy

64 ponents of the hematopoietic system that are radioprotective, we transplanted lethally irradiated mic